litlas
ログインアカウント作成

Kenneth B. Gordon

1988–2025 年に発表

94
論文数
21,915
被引用数
71
h 指数
90
i10 指数

被引用数

Kenneth B. Gordon の年別被引用数1989 年: 被引用 2 件1990 年: 被引用 5 件1992 年: 被引用 2 件1994 年: 被引用 1 件1995 年: 被引用 3 件1996 年: 被引用 1 件1997 年: 被引用 3 件1998 年: 被引用 20 件1999 年: 被引用 29 件2000 年: 被引用 24 件2001 年: 被引用 18 件2002 年: 被引用 14 件2003 年: 被引用 19 件2004 年: 被引用 24 件2005 年: 被引用 31 件2006 年: 被引用 44 件2007 年: 被引用 66 件2008 年: 被引用 76 件2009 年: 被引用 114 件2010 年: 被引用 115 件2011 年: 被引用 165 件2012 年: 被引用 151 件2013 年: 被引用 165 件2014 年: 被引用 141 件2015 年: 被引用 162 件2016 年: 被引用 168 件2017 年: 被引用 272 件2018 年: 被引用 259 件2019 年: 被引用 716 件2020 年: 被引用 821 件2021 年: 被引用 798 件2022 年: 被引用 659 件2023 年: 被引用 616 件2024 年: 被引用 899 件2025 年: 被引用 446 件2026 年: 被引用 2 件1991 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,745 件、この内訳の 24.1%ドイツ: 引用元論文 572 件、この内訳の 7.9%イギリス: 引用元論文 530 件、この内訳の 7.3%カナダ: 引用元論文 519 件、この内訳の 7.2%イタリア: 引用元論文 403 件、この内訳の 5.6%中国: 引用元論文 362 件、この内訳の 5%フランス: 引用元論文 310 件、この内訳の 4.3%スペイン: 引用元論文 260 件、この内訳の 3.6%日本: 引用元論文 257 件、この内訳の 3.5%スイス: 引用元論文 198 件、この内訳の 2.7%オランダ: 引用元論文 192 件、この内訳の 2.6%デンマーク: 引用元論文 167 件、この内訳の 2.3%
0%24.1%その他 23.9%

機関

分野

  • Immunology and Microbiology56.2%
  • Medicine31.1%
  • Biochemistry, Genetics and Molecular Biology7.3%
  • Neuroscience2.6%
  • Pharmacology, Toxicology and Pharmaceutics1.2%
  • Materials Science0.4%
  • その他1.2%

トピック

  • Psoriasis: Treatment and Pathogenesis21.5%
  • Dermatology and Skin Diseases10.8%
  • Spondyloarthritis Studies and Treatments10.2%
  • Rheumatoid Arthritis Research and Therapies4.6%
  • Asthma and respiratory diseases2.5%
  • Inflammatory Bowel Disease2.4%
  • その他48%

共著者

全論文

検索で開く
  1. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics

    著者: Alan Menter, Bruce Strober, Daniel H. Kaplan, Darío Kivelevitch, Elizabeth Farley Prater, Benjamin K. Stoff, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Arthur Kavanaugh, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Reena Rupani, Michael Siegel, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets - Journal of the American Academy of Dermatology 2019 被引用: 924

  2. Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial

    著者: Bruce Strober, Diamant Thaçi, Howard Sofen, Leon Kircik, Kenneth B. Gordon, Peter Foley, Phoebe Rich, C. Paul, Jerry Bagel, Elizabeth Colston, John Throup, Sudeep Kundu, Chitra Sekaran, Misti Linaberry, Subhashis Banerjee, Kim Papp - Journal of the American Academy of Dermatology 2022 被引用: 279

  3. Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo- and active comparator–controlled VOYAGE 2 trial

    著者: Kristian Reich, April W. Armstrong, Peter Foley, Michael Song, Yasmine Wasfi, B. Randazzo, Shu Li, Yaung‐Kaung Shen, Kenneth B. Gordon - Journal of the American Academy of Dermatology 2017 被引用: 731

  4. Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis

    著者: Kenneth B. Gordon, Andrew Blauvelt, Kim Papp, Richard G. Langley, Thomas A. Luger, Mamitaro Ohtsuki, Kristian Reich, David A. Amato, Susan Ball, Daniel Braun, Gregory S. Cameron, J. Erickson, Robert J. Konrad, Talia M. Muram, Brian J. Nickoloff, Olawale Osuntokun, Roberta J. Secrest, Fangyi Zhao, Lotus Mallbris, Craig L. Leonardi - New England Journal of Medicine 2016 被引用: 838

  5. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials

    著者: Kenneth B. Gordon, Bruce Strober, Mark Lebwohl, Matthias Augustin, Andrew Blauvelt, Yves Poulin, Kim Papp, Howard Sofen, L. Puig, Peter Foley, Mamitaro Ohtsuki, Mary Flack, Ziqian Geng, Yihua Gu, Joaquin Valdes, Elizabeth H. Thompson, H. Bachelez - The Lancet 2018 被引用: 662

  6. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities

    著者: Craig A. Elmets, Craig L. Leonardi, Dawn Marie R. Davis, Joel M. Gelfand, Jason Lichten, Nehal N. Mehta, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Darío Kivelevitch, Matthew Kiselica, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Henry W. Lim, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth Farley Prater, Reena Rupani, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Alan Menter - Journal of the American Academy of Dermatology 2019 被引用: 486

  7. Bimekizumab versus ustekinumab for the treatment of moderate to severe plaque psoriasis (BE VIVID): efficacy and safety from a 52-week, multicentre, double-blind, active comparator and placebo controlled phase 3 trial

    著者: Kristian Reich, Kim Papp, Andrew Blauvelt, Richard G. Langley, April W. Armstrong, Richard B. Warren, Kenneth B. Gordon, Joseph F. Merola, Yukari Okubo, Cynthia Madden, Maggie Haitian Wang, Christopher L. Cioffi, Veerle Vanvoorden, Mark Lebwohl - The Lancet 2021 被引用: 297

  8. Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial

    著者: Kenneth B. Gordon, Peter Foley, James G. Krueger, Andreas Pinter, Kristian Reich, Ronald Vender, Veerle Vanvoorden, Cynthia Madden, Katy White, Christopher L. Cioffi, Andrew Blauvelt - The Lancet 2021 被引用: 284

  9. Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)

    著者: Kim Papp, Kristian Reich, Craig L. Leonardi, Leon Kircik, Sergio Chimenti, Richard G. Langley, ChiaChi Hu, Randall M. Stevens, Robert M. Day, Kenneth B. Gordon, Neil J. Korman, C.E.M. Griffiths - Journal of the American Academy of Dermatology 2015 被引用: 669

  10. Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis

    著者: Mark Lebwohl, Bruce Strober, Alan Menter, Kenneth B. Gordon, Jolanta Węgłowska, L. Puig, Kim Papp, Lynda Spelman, Darryl Toth, Francisco A. Kerdel, April W. Armstrong, Georg Stingl, Alexa B. Kimball, H. Bachelez, Jashin J. Wu, Jeffrey Crowley, Richard G. Langley, Tomasz Blicharski, C. Paul, J.‐P. Lacour, Stephen K. Tyring, Leon Kircik, Sergio Chimenti, Kristina Callis Duffin, Jerry Bagel, John Koo, Gary Aras, Joanne Li, Wenjie Song, Cassandra E. Milmont, Yifei Shi, Ngozi Erondu, Paul Klekotka, Brian L. Kotzin, Ajay Nirula - New England Journal of Medicine 2015 被引用: 806

  11. Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis

    著者: Kim Papp, Kenneth B. Gordon, Diamant Thaçi, Akimichi Morita, Melinda Gooderham, Peter Foley, Ihab Girgis, Sudeep Kundu, Subhashis Banerjee - New England Journal of Medicine 2018 被引用: 414

  12. Joint AAD–NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures

    著者: Craig A. Elmets, Neil J. Korman, Elizabeth Farley Prater, Emily Wong, Reena Rupani, Darío Kivelevitch, April W. Armstrong, Cody Connor, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Jashin J. Wu, Vidhya Hariharan, Alan Menter - Journal of the American Academy of Dermatology 2020 被引用: 329

  13. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies

    著者: Alan Menter, Joel M. Gelfand, Cody Connor, April W. Armstrong, Kelly M. Cordoro, Dawn Marie R. Davis, Boni E. Elewski, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Darío Kivelevitch, Neil J. Korman, Daniela Kroshinsky, Mark Lebwohl, Craig L. Leonardi, Jason Lichten, Henry W. Lim, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth Farley Prater, Robert S. Rahimi, Reena Rupani, Michael Siegel, Benjamin K. Stoff, Bruce Strober, Elliot B. Tapper, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Craig A. Elmets - Journal of the American Academy of Dermatology 2020 被引用: 331

  14. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

    著者: Craig L. Leonardi, Alexa B. Kimball, Kim Papp, Newman Yeilding, Cynthia Guzzo, Yuhua Wang, Shu Li, Lisa T. Dooley, Kenneth B. Gordon - The Lancet 2008 被引用: 1,865

  15. Association between biological immunotherapy for psoriasis and time to incident inflammatory arthritis: a retrospective cohort study

    著者: Shikha Singla, Michael Putman, Jean W. Liew, Kenneth B. Gordon - The Lancet Rheumatology 2023 被引用: 96

  16. Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial

    著者: Akimichi Morita, Bruce Strober, A. David Burden, Siew Eng Choon, Milan J. Anadkat, Slaheddine Marrakchi, Tsen‐Fang Tsai, Kenneth B. Gordon, Diamant Thaçi, Min Zheng, Na Hu, Thomas Haeufel, Christian Thoma, Mark Lebwohl - The Lancet 2023 被引用: 110

  17. Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis*

    著者: Kenneth B. Gordon, Mark Lebwohl, Kim Papp, H. Bachelez, Jashin J. Wu, Richard G. Langley, Andrew Blauvelt, Beth Kaplan, Megha Shah, Yiwei Zhao, Ranjeeta Sinvhal, Kristian Reich - British Journal of Dermatology 2021 被引用: 99

  18. A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, double‐blinded trial

    著者: Andrew Blauvelt, Kim Papp, Alice B. Gottlieb, Abel Jarell, Kristian Reich, Catherine Maari, Kenneth B. Gordon, Laura K. Ferris, Richard G. Langley, Yayoi Tada, Renata Gontijo Lima, Hany Elmaraghy, Gaia Gallo, L. Renda, S‐M. Park, Russel Burge, Jerry Bagel, the IXORA‐R Study Group, Ronald Vender, Mark Lomaga, Isabelle Delorme, Chih-ho Hong, Richard L. Langley, Lorne Albrecht, Lyn Guenther, Catherine Maari, Kim Papp, Kamal Ohson, Kirk Barber, Charles Lynde, Aditya Gupta, Leslie Rosoph, Jean‐Sébastien Gauthier, Melinda Gooderham, Norman Wasel, Mani Raman, Marni Wiseman, David Greenstein, Abel Jarell, C. A. L. Moon, Lani Clark, S. Jazayeri, Michael Bukhalo, Angela Moore, Tiffani K. Hamilton, Aron Gewirtzman, Lydie Hazan, Jeffrey Crowley, Craig Teller, Matthew Zirwas, Stacy Smith, Mark Lee, Stephen K. Tyring, Patricia Lee, Sunil Dhawan, Craig L. Leonardi, Amarilis Perez‐De Jesus, Wendy McFalda, Ellen Frankel, Paul S. Yamauchi, Scott Fretzin, Rocco Serrao, Todd Schlesinger, Scott Gottlieb, Peter Jenkin, Rola Gharib, Steven A. Davis, Navid Nami, Zoe Diana Draelos, Lloyd Godwin, Cindy E. Owen, Megan N. Landis, William Abramovits, Samuel Sanchez‐Rivera, Abby Van Voorhees, David Fivenson, Francisco A. Kerdel, Seth Forman, Jeffrey S. Weinberg, José González-Chávez, Brent Boyce, Linda Stein‐Gold, Charles P. Hudson, Constance Brown, James Coggi, Christina Feser, Rion Forconi, Sandra Johnson, Mark McCune, Lawrence Green, Vandana Madkan, Dana Maxwell Shipp, Kenneth B. Gordon, Jill Waibel, Oscar Soto‐Raices, Jennifer Cather, Scott Miller, John P. Scott, Douglas Young, Jessica Kaffenberger ほか 42 名 - British Journal of Dermatology 2019 被引用: 172

  19. Five‐year maintenance of clinical response and health‐related quality of life improvements in patients with moderate‐to‐severe psoriasis treated with guselkumab: results from VOYAGE 1 and VOYAGE 2*

    著者: Kristian Reich, Kenneth B. Gordon, Bruce Strober, April W. Armstrong, Megan Miller, Yaung‐Kaung Shen, Yin You, Chenglong Han, Ya‐Wen Yang, Peter Foley, C.E.M. Griffiths - British Journal of Dermatology 2021 被引用: 81

  20. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease

    著者: Gerd R Burmester, Remo Panaccione, Kenneth B. Gordon, M. McIlraith, Ana P. Lacerda - Annals of the Rheumatic Diseases 2012 被引用: 586

  21. Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

    著者: Alan Menter, Stephen K. Tyring, Kenneth B. Gordon, Alexa B. Kimball, Craig L. Leonardi, Richard G. Langley, Bruce Strober, Martin Kaul, Yihua Gu, Martin M. Okun, Kim Papp - Journal of the American Academy of Dermatology 2007 被引用: 883

  22. Guidelines of care for the management of psoriasis and psoriatic arthritis

    著者: Alan Menter, Neil J. Korman, Craig A. Elmets, Steven R. Feldman, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, John Koo, Mark Lebwohl, Craig L. Leonardi, Henry W. Lim, Abby S. Van Voorhees, Karl R. Beutner, Caitriona Ryan, Reva Bhushan - Journal of the American Academy of Dermatology 2011 被引用: 454

  23. Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

    著者: Richard G. Langley, Steven R. Feldman, Chenglong Han, Brad Schenkel, Philippe Szapary, Ming-Chun Hsu, Jean-Paul Ortonne, Kenneth B. Gordon, Alexa B. Kimball - Journal of the American Academy of Dermatology 2010 被引用: 216

  24. Joint American Academy of Dermatology–National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy

    著者: Craig A. Elmets, Henry W. Lim, Benjamin K. Stoff, Cody Connor, Kelly M. Cordoro, Mark Lebwohl, April W. Armstrong, Dawn Marie R. Davis, Boni E. Elewski, Joel M. Gelfand, Kenneth B. Gordon, Alice B. Gottlieb, Daniel H. Kaplan, Arthur Kavanaugh, Matthew Kiselica, Darío Kivelevitch, Neil J. Korman, Daniela Kroshinsky, Craig L. Leonardi, Jason Lichten, Nehal N. Mehta, Amy S. Paller, Sylvia L. Parra, Arun L. Pathy, Elizabeth A. Farley Prater, Reena Rupani, Michael Siegel, Bruce Strober, Emily Wong, Jashin J. Wu, Vidhya Hariharan, Alan Menter - Journal of the American Academy of Dermatology 2019 被引用: 190